Market Share of Multiple Sclerosis Therapeutics Industry
The multiple sclerosis therapeutics market is moderately competitive, as there are few players in this market. These companies are the big pharmaceutical companies focusing on pipeline drugs for multiple sclerosis. With the rising R&D investment in the pharmaceutical industry, it is believed that more companies may enter the market studied in the future, and the competition may increase. A few of the major companies currently dominating the market are Biogen Inc., Novartis AG, Merck KGaA, Sanofi, and Acorda Therapeutics, Inc., among others.
Multiple Sclerosis Therapeutics Market Leaders
-
Biogen Inc.
-
Novartis AG
-
Merck KGaA
-
Sanofi S. A.
-
Acorda Therapeutics, Inc.
*Disclaimer: Major Players sorted in no particular order